Pharma Equity Group A/S

PEG.CO · CPH
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-DKK 26-DKK 27DKK 3DKK 5
Dep. & Amort.DKK 0DKK 0DKK 0DKK 0
Deferred TaxDKK 0DKK 0-DKK 0DKK 0
Stock-Based Comp.DKK 0DKK 0DKK 0DKK 0
Change in WCDKK 0DKK 3DKK 2-DKK 0
Other Non-CashDKK 3DKK 6-DKK 8-DKK 7
Operating Cash Flow-DKK 23-DKK 17-DKK 3-DKK 2
Investing Activities
PP&E Inv.DKK 0-DKK 0DKK 0DKK 0
Net AcquisitionsDKK 0DKK 0DKK 0DKK 0
Inv. PurchasesDKK 0DKK 0DKK 0DKK 0
Inv. Sales/Matur.DKK 0DKK 0DKK 0DKK 0
Other Inv. Act.DKK 0DKK 0DKK 0DKK 0
Investing Cash FlowDKK 0-DKK 0DKK 0DKK 0
Financing Activities
Debt Repay.-DKK 20DKK 9DKK 3DKK 2
Stock IssuedDKK 51DKK 12DKK 0DKK 0
Stock Repurch.DKK 0DKK 0DKK 0DKK 0
Dividends PaidDKK 0DKK 0DKK 0DKK 0
Other Fin. Act.-DKK 8-DKK 4DKK 0DKK 0
Financing Cash FlowDKK 23DKK 17DKK 3DKK 2
Forex EffectDKK 0DKK 1DKK 0DKK 0
Net Chg. in CashDKK 0DKK 1DKK 0DKK 0
Supplemental Information
Beg. CashDKK 4DKK 3DKK 0DKK 0
End CashDKK 4DKK 4DKK 0DKK 0
Free Cash Flow-DKK 23-DKK 17-DKK 3-DKK 2
Pharma Equity Group A/S (PEG.CO) Financial Statements & Key Stats | AlphaPilot